Inside the largest known lab making billions for the Assad regime

Caroline Rose, director of the New York-based New Lines Institute Captagon Trade Project, said the global trade in the drug has an estimated value of $US10 billion ($15.7 billion) and put the ousted Syrian leadership’s annual profit from it at about $US2.4 billion.